Cargando…
A Modified in vitro Clot Lysis Assay Predicts Outcomes in Non-traumatic Intracerebral Hemorrhage Stroke Patients—The IRONHEART Study
Background: Non-traumatic intracerebral hemorrhage (ICH) accounts for 10–15% of all strokes and results in a higher rate of mortality as compared to ischemic strokes. In the IRONHEART study, we aimed to find out whether a modified in vitro clot lysis assay method, that includes the effect of neutrop...
Autores principales: | Orbán-Kálmándi, Rita, Árokszállási, Tamás, Fekete, István, Fekete, Klára, Héja, Máté, Tóth, Judit, Sarkady, Ferenc, Csiba, László, Bagoly, Zsuzsa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8093390/ https://www.ncbi.nlm.nih.gov/pubmed/33959087 http://dx.doi.org/10.3389/fneur.2021.613441 |
Ejemplares similares
-
Prognostic Value of Various Hemostasis Parameters and Neurophysiological Examinations in Spontaneous Intracerebral Hemorrhage: The IRONHEART Study Protocol
por: Árokszállási, Tamás, et al.
Publicado: (2021) -
Neurophysiological Examinations as Adjunctive Tool to Imaging Techniques in Spontaneous Intracerebral Hemorrhage: IRONHEART Study
por: Fekete, Klára, et al.
Publicado: (2021) -
Thrombin generation as a predictor of outcomes in patients with non-traumatic intracerebral hemorrhage
por: Lóczi, Linda, et al.
Publicado: (2022) -
A modified in vitro clot lysis assay predicts outcomes and safety in acute ischemic stroke patients undergoing intravenous thrombolysis
por: Orbán-Kálmándi, Rita, et al.
Publicado: (2021) -
Incorporation of α2-Plasmin Inhibitor into Fibrin Clots and Its Association with the Clinical Outcome of Acute Ischemic Stroke Patients
por: Bagoly, Zsuzsa, et al.
Publicado: (2021)